Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-070131
Filing Date
2023-03-14
Accepted
2023-03-14 16:05:35
Documents
5
Effectiveness Date
2023-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d475628ds8.htm S-8 43412
2 EX-5.1 d475628dex51.htm EX-5.1 6532
3 EX-23.1 d475628dex231.htm EX-23.1 1548
4 EX-FILING FEES d475628dexfilingfees.htm EX-FILING FEES 27183
5 GRAPHIC g475628g50m98.jpg GRAPHIC 3293
  Complete submission text file 0001193125-23-070131.txt   84433
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270523 | Film No.: 23730726
SIC: 2834 Pharmaceutical Preparations